Please login to the form below

Not currently logged in
Email:
Password:

drug development

This page shows the latest drug development news and features for those working in and with pharma, biotech and healthcare.

Novartis forges AI alliance with Oxford University

Novartis forges AI alliance with Oxford University

to improve drug development, as well as Novartis’ in-house data sets. ... change how we look at diseases and discover new insights” said John Tsai, Novartis’ head of global drug development and chief medical officer.

Latest news

  • FDA expecting boom in cell and gene therapies FDA expecting boom in cell and gene therapies

    for cancer from Novartis and Gilead/Kite Pharma, and there are plenty more in mid- to late-stage development. ... A more traditional approach to drug development may be more appropriate “if the gene therapy creates a genetic alteration aimed at

  • Horizon Discovery and C4X to harness CRISPR for new cancer drugs Horizon Discovery and C4X to harness CRISPR for new cancer drugs

    synthetic lethality drug targets is a key priority to develop new therapies for cancer patients who are not responsive to current treatments.”. ... C4XD will fund the work plan and if it discovers pre-clinical drug candidates for these novel, synthetic

  • AZ and CRUK launch Cambridge genomics centre AZ and CRUK launch Cambridge genomics centre

    disease - and how this knowledge can result in faster, more accurate drug discovery. ... Knowing the functional genomic drivers of disease increases the probability of success in drug discovery and early development, giving scientists an edge when it

  • Zafgen shares tumble after FDA places hold on diabetes trial Zafgen shares tumble after FDA places hold on diabetes trial

    possible cardiovascular safety risks associated with ZGN-1061, currently in development for type 2 diabetes. ... The FDA has halted the drug’s clinical trial development at the preliminary Investigational New Drug Application (IND) stage because of

  • Entering the era of digital trials Entering the era of digital trials

    If sponsors can clear the remaining bottlenecks, the era of end-to- end digital drug development will begin. ... End-to-end digital drug development is coming. The question is how soon. .

More from news
Approximately 21 fully matching, plus 771 partially matching documents found.

Latest Intelligence

  • China’s clinical trial shake-up China’s clinical trial shake-up

    The surge in clinical trial activity in China has happened, in part, because of the blossoming of drug development in the country. ... A drug control institute or third-party laboratory tests drug samples to verify compliance with quality standards.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Pangalos swiftly recruited oncologist Susan Galbraith, then working at Bristol- Myers Squibb, to head AstraZeneca’s IMED oncology team, which focused on small molecule drug development in oncology. ... Despite progress here and across the industry,

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    Drug development is outpacing our capacity to develop biomarkers due to the complexity of the cancer immune response. ... However, drug development is seldom only about the patients. Article by.

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    It already invests hugely in long-term development programmes to understand drug efficacy and safety; the step required to take the same long-term view on implementing behaviour change programmes is ... If behavioural aspects are investigated and

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    ‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’. ... By Dr Peter Schueler, Senior Vice President, Drug Development Services and Haichen Yang, Vice President, Global Therapeutic Lead, both at CNS, ICON plc.

More from intelligence
Approximately 6 fully matching, plus 100 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    I am delighted to welcome Frank to the team at this exciting stage in the company’s development. ... The combination of his strong experience in regulatory affairs, not only with the FDA but on a broad international basis with a proven track record and

  • New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

    Mader brings a track record of drug discovery experience to the biotech, most recently working for Eli Lilly, where she contributed to the development of multiple clinical candidates. ... Meanwhile, Mahesh Padval also joins Relay as senior vice president

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries. ... Atkins said: “Britten joins our Senior Management team at a pivotal time in the Company’s development.

  • Pharma industry appointments Pharma industry appointments

    activities and continues to advance its lead drug candidate, XF-73, through clinical development.”. ... Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28

  • Weekly industry appointments Weekly industry appointments

    approval. Prior to this, Appleby served as project leader and portfolio manager at the GSK Centre of Excellence for External Drug Development. ... Commenting on the new appointment, Keith Thompson, chief executive of CGT Catapult, said: “With over 20

More from appointments
Approximately 1 fully matching, plus 169 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics